secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2024-05-23T23:59:59+00:00
Accession:  0001493152-24-021096
Event type: regulatory
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Enveric Biosciences regains Nasdaq equity compliance; bid price deficiency remains
--------------------------------------------------------------------------------

- Received Nasdaq letter on May 21, 2024 confirming compliance with minimum stockholders' equity requirement.
- Stockholders' equity as of March 31, 2024 was $6,481,856.
- Minimum bid price deficiency under Nasdaq Rule 5550(a)(2) remains outstanding.
- Company intends to monitor bid price and consider available options to resolve the deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315224021096/0001493152-24-021096-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315224021096/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-021096

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer